Management of non-motor complications in Parkinson's disease

被引:10
|
作者
Fujimoto, Ken-ichi [1 ]
机构
[1] Jichi Med Univ, Dept Neurol, Shimotsuke, Tochigi 3290498, Japan
关键词
Psychosis; Mianserin hydrochloride; Deep brain stimulation; Leg-holding exercise; Mood disorders; RISK-FACTORS; DOUBLE-BLIND; PSYCHOSIS; HALLUCINATIONS; DYSREGULATION; QUETIAPINE; DISORDERS; MIANSERIN; DRUGS;
D O I
10.1007/s00415-009-5245-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This paper summarizes the methods we devised for the treatment of psychosis, orthostatic hypotension, and mood disorders among the various non-motor complications of Parkinson's disease. Psychosis may not manifest when a patient believes in his/her delusions. If left untreated over a prolonged period, however, the delusions progress to paranoia that is very difficult to cure. Accordingly, enquiries should be made during routine examinations to detect the presence of psychosis and facilitate early discovery. Atypical antipsychotics are used when psychosis does not improve after reducing the doses of antiparkinson drugs. We achieved favorable results by using mianserin hydrochloride prior to this step, with efficacy being observed for hallucinations and mild delusions that often manifested at night. This drug does not act as a dopamine receptor blocker, so it has the advantage of not aggravating motor symptoms. With this therapy, it is also possible to improve motor symptoms without inducing psychosis by reducing the doses of antiparkinson drugs and locally stimulating the motor loop by deep brain stimulation of the subthalamic nucleus. We previously introduced leg-holding exercises for the treatment of orthostatic hypotension, through which blood pooled in the veins is returned to the systemic circulation by holding the knees. This can be done easily and is free of adverse reactions. Mood disorders are difficult to cope with in patients with Parkinson's disease, but may be treated by selecting an appropriate dopamine agonist while giving consideration to affinity for the dopamine D3 receptor. However, treatment becomes complicated when the dopamine receptor is overstimulated. Here we report on cases of successfully treated pathological gambling and dopamine dysregulation syndrome, which are considered difficult to manage. The solution may differ depending on a patient's environment, and it is not easy to prescribe therapy based on evidence-based medicine. The best therapy should be selected by maintaining communication with the patient and developing a relationship built on trust.
引用
收藏
页码:S299 / S305
页数:7
相关论文
共 50 条
  • [31] Non-motor symptoms in Parkinson's disease
    Poewe, W.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 14 - 20
  • [32] NON-MOTOR SYMPTOMS OF PARKINSON'S DISEASE
    Jiwani, S. B.
    [J]. AGE AND AGEING, 2014, 43
  • [33] NON-MOTOR MANIFESTSTIONS OF PARKINSON'S DISEASE
    Henyk, S. I.
    Hryb, V. A.
    Doroshenko, O. O.
    Maksymchuk, L. T.
    Henyk, S. M.
    Henyk, Ya. I.
    [J]. WORLD OF MEDICINE AND BIOLOGY, 2019, 68 (02): : 39 - 43
  • [34] Non-motor symptoms in Parkinson's disease
    Park, Ariane
    Stacy, Mark
    [J]. JOURNAL OF NEUROLOGY, 2009, 256 : S293 - S298
  • [35] Parkinson's disease: The non-motor issues
    Chaudhuri, K. Ray
    Odin, Per
    Antonini, Angelo
    Martinez-Martin, Pablo
    [J]. PARKINSONISM & RELATED DISORDERS, 2011, 17 (10) : 717 - 723
  • [36] Non-motor symptoms in Parkinson’s disease
    Ariane Park
    Mark Stacy
    [J]. Journal of Neurology, 2009, 256 : 293 - 298
  • [37] Non-motor symptoms in Parkinson's disease
    Barbosa, Egberto Reis
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (04) : 203 - 204
  • [38] Non-motor symptoms in Parkinson's disease
    Pfeiffer, Ronald F.
    [J]. PARKINSONISM & RELATED DISORDERS, 2016, 22 : S119 - S122
  • [39] Non-motor symptoms burden is greater in early Parkinson's disease patients with motor complications
    Santos, D.
    de Deus, T.
    Suarez Castro, E.
    Aneiros, A.
    Jesus, S.
    Aguilar, M.
    Planellas, L. L.
    Garcia Caldentey, J.
    Caballol, N.
    Vives, B.
    Hernandez Vara, J.
    Cabo, I.
    Lopez Manzanares, L.
    Gonzalez Aramburu, I.
    Avila, M. A.
    Catalan, M. J.
    Lopez Diaz, L.
    Garcia Moreno, J. M.
    Solano, B.
    Alvarez Sauco, M.
    Vela, L.
    Escalante, S.
    Cubo, E.
    Carrillo, F.
    Martinez Castrillo, J. C.
    Sanchez Alonso, P.
    Alonso Losada, M. G.
    Lopez Ariztegui, N.
    Martinez Martin, P.
    Coppadis, S. G.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S661 - S661
  • [40] Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
    Bastide, Matthieu F.
    Meissner, Wassilios G.
    Picconi, Barbara
    Fasano, Stefania
    Fernagut, Pierre-Olivier
    Feyder, Michael
    Francardo, Veronica
    Alcacer, Cristina
    Ding, Yunmin
    Brambilla, Riccardo
    Fisone, Gilberto
    Stoessl, A. Jon
    Bourdenx, Mathieu
    Engeln, Michel
    Navailles, Sylvia
    De Deurwaerdere, Philippe
    Ko, Wai Kin D.
    Simola, Nicola
    Morelli, Micaela
    Groc, Laurent
    Rodriguez, Maria-Cruz
    Gurevich, Eugenia V.
    Quik, Maryka
    Morari, Michele
    Mellone, Manuela
    Gardoni, Fabrizio
    Tronci, Elisabetta
    Guehl, Dominique
    Tison, Francois
    Crossman, Alan R.
    Kang, Un Jung
    Steece-Collier, Kathy
    Fox, Susan
    Carta, Manolo
    Cenci, M. Angela
    Bezard, Erwan
    [J]. PROGRESS IN NEUROBIOLOGY, 2015, 132 : 96 - 168